日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.

组蛋白甲基转移酶 KMT2D 是去势抵抗性前列腺癌谱系可塑性和治疗反应的关键介质。

Kittane Srushti, Ladewig Erik, Li Taibo, Love Jillian R, Blawski Ryan, Gao Yangzhenyu, Arruabarrena-Aristorena Amaia, Zhao Peihua, Dalrymple Susan L, Liu Huayang, Guo Xinyu, Sallaku Mirna, Kelkar Nachiket, Garcia-Martinez Liliana, Carmona Sanz Javier, Chen Wanlu, Stoudmann Candice, Baldino Laura, Razavi-Mohseni Milad, Kalemi Ingrid, Beer Michael A, Castel Pau, Brennen W Nathaniel, Scaltriti Maurizio, Morey Lluis, Cocco Emiliano, Ji Hongkai, Chan Ho Man, Battle Alexis, Leslie Christina S, Karthaus Wouter R, Toska Eneda

Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)

晚期胰腺腺癌患者二线化疗总生存期和治疗持续时间的预测标准(AIO-PAK-0216)

Lutz, Manfred P; Ansorge, Nikolaus; Barmashenko, Gleb; Bauer, Hans; Burkart, Christof; Decker, Thomas; Ettrich, Thomas; Fischer von Weikersthal, Ludwig; Geer, Thomas; Gerhardt, Anke; Höfling, Sabine; Jacobasch, Lutz; Koenigsmann, Michael; Leidig, Tobias; Plentz, Ruben; Räth, Sebastian; Reichert, Dietmar; Schulte, Markos; Schulte, Nadine; Schwarzer, Andreas; Siegler, Gabriele; Waldschmidt, Dirk; Karthaus, Meinolf

Disseminated Lomentospora prolificans infection in a patient with neutropenia treated with ipilimumab and nivolumab

接受伊匹木单抗和纳武单抗治疗的中性粒细胞减少症患者发生播散性洛门托孢子菌感染

Dunstan, Nicholas William; Robinson, James Owen; Walczak, Andrew; Higgins, Ammie; Karthaus, Meinolf; Ariyapperuma, Mihitha Hashara

An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial

免疫反应性肿瘤微环境可印刻外周血单核细胞 (PBMC) 并预测晚期胰腺癌的预后:来自 PREDICT 试验的启示

Lahusen, Anton; Lutz, Manfred P; Fang, Rui; Kirchner, Martina; Albus, Sarah; Kluck, Klaus; Karthaus, Meinolf; Schwarzer, Andreas; Siegler, Gabriele; Kleger, Alexander; Ettrich, Thomas J; Becher, Alexander; Höfling, Sabine; Siveke, Jens T; Budczies, Jan; Tannapfel, Andrea; Stenzinger, Albrecht; Cheung, Phyllis Fung-Yi; Eiseler, Tim; Seufferlein, Thomas

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies

2024 年 AGIHO 指南更新:成人中性粒细胞减少症合并实体瘤和血液系统恶性肿瘤患者不明原因发热 (FUO) 的诊断和经验性治疗

Sandherr, Michael; Stemler, Jannik; Schalk, Enrico; Hattenhauer, Tessa; Hentrich, Marcus; Hertenstein, Bernd; Hohmann, Christian; Mellinghoff, Sibylle C; Mispelbaum, Rebekka; Rieger, Christina; Schmidt-Hieber, Martin; Sprute, Rosanne; Weiss, Guenter; Cornely, Oliver A; Henze, Larissa; Lass-Floerl, Cornelia; Beutel, Gernot; Classen, Annika Y; Freise, Noemi F; Karthaus, Meinolf; Koehler, Philipp; Krause, Robert; Neuhann, Julia; Orth, Hans Martin; Penack, Olaf; Schaich, Markus; Spiekermann, Karsten; Voigt, Sebastian; Weissinger, Florian; Busch, Elena

Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial

帕尼单抗联合 5-氟尿嘧啶和亚叶酸钙或单独使用 5-氟尿嘧啶和亚叶酸钙作为 RAS 野生型转移性结直肠癌的维持治疗(PanaMa,AIO KRK 0212):一项随机、开放标签、II 期试验的最终疗效分析

Stahler, Arndt; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel H S; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P

BRCA2 reversion mutation-independent resistance to PARP inhibition through impaired DNA prereplication complex function.

BRCA2 逆转突变非依赖性 PARP 抑制剂耐药性,通过损害 DNA 复制前复合物功能实现

Pappas Kyrie, Ferrari Matteo, Smith Perianne, Nandakumar Subhiksha, Khan Zahra, Young Serina B, LaClair Justin, Russo Marco Vincenzo, Huang-Hobbs Emmet, Schultz Nikolaus, Abida Wassim, Karthaus Wouter, Jasin Maria, L Sawyers Charles

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study

评估循环肿瘤DNA作为BRAF V600E突变型结直肠癌的预后和预测生物标志物——FIRE-4.5研究结果

Klein-Scory, Susanne; Baraniskin, Alexander; Schmiegel, Wolff; Mika, Thomas; Schroers, Roland; Held, Swantje; Heinrich, Kathrin; Tougeron, David; Modest, Dominik P; Schwaner, Ingo; Eucker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Müller, Christian; Burkart, Christof; Stintzing, Sebastian; Heinemann, Volker

CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation

CDC7 抑制通过 MYC 降解损害肺癌和前列腺肿瘤中的神经内分泌转化

Alvaro Quintanal-Villalonga, Kenta Kawasaki #, Esther Redin #, Fathema Uddin #, Swanand Rakhade #, Vidushi Durani, Amin Sabet, Moniquetta Shafer, Wouter R Karthaus, Samir Zaidi, Yingqian A Zhan, Parvathy Manoj, Harsha Sridhar, Dennis Kinyua, Hong Zhong, Barbara P Mello, Metamia Ciampricotti, Umesh K

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1

前列腺癌中的神经内分泌转变是动态的,并且依赖于 ASCL1

Rodrigo Romero, Tinyi Chu #, Tania J González Robles #, Perianne Smith #, Yubin Xie, Harmanpreet Kaur, Sara Yoder, Huiyong Zhao, Chenyi Mao, Wenfei Kang, Maria V Pulina, Kayla E Lawrence, Anuradha Gopalan, Samir Zaidi, Kwangmin Yoo, Jungmin Choi, Ning Fan, Olivia Gerstner, Wouter R Karthaus, Elisa D